medroxyprogesterone acetate has been researched along with Depression in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.17) | 18.7374 |
1990's | 6 (25.00) | 18.2507 |
2000's | 10 (41.67) | 29.6817 |
2010's | 5 (20.83) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Miller, ES; Ross, CM; Shim, JY; Stark, EL; Wisner, KL | 1 |
Balakrishna, Y; Carayon-Lefebvre d'Hellencourt, F; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M | 1 |
Carayon-Lefebvre d'Hellencourt, F; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M | 1 |
Gur, TL; Schaffir, J; Worly, BL | 1 |
Braun-Courville, D; Francis, J; Linares, LO; Malbon, K; Presser, L | 1 |
Heberle, AE; Joffe, H; Rogines-Velo, MP | 1 |
Abou-Abdallah, M; Awwad, JT; Farra, CG; Ghazeeri, GS; Hannoun, A; Isaacson, K | 1 |
Thacker, HL | 1 |
Bäckström, G; Bäckström, T; Bixo, M; Björn, I; Nyberg, S; Sundström-Poromaa, I | 1 |
Bäckström, T; Bixo, M; Jonsson, B; Odmark, IS | 1 |
Alessandrini, C; Arangino, S; Baldassari, F; Cagnacci, A; Landi, S; Volpe, A | 1 |
Brunner, R; Coker, LH; Espeland, MA; Granek, IA; Hogan, P; Maki, PM; Ockene, JK; Rapp, SR; Resnick, SM; Shumaker, SA | 1 |
Tiezzi, L; Westhoff, C; Wieland, D | 1 |
Paul, C; Skegg, DC; Williams, S | 1 |
Cushman, L; Davidson, A; Heartwell, S; Kalmuss, D; Rulin, M; Truman, C; Westhoff, C | 1 |
Boroditsky, RS | 1 |
Barlow, WE; Civic, D; Ichikawa, L; LaCroix, AZ; Ott, SM; Scholes, D; Yoshida, CK | 1 |
Ozer, S; Soysal, ME; Soysal, S; Vicdan, K | 1 |
Bergqvist, A; Theorell, T | 1 |
Davis, A; Gupta, N; Jacobsen, LJ; Kulig, J; O'Brien, R; Supran, S; Zuckerman, A | 1 |
Boothroyd, D; Hlatky, MA; Sharp, P; Vittinghoff, E; Whooley, MA | 1 |
Battistutta, D; Coglan, M; Khoo, SK; Raphael, B; Tippett, V | 1 |
Baber, R; Heller, GZ; Nand, SL; Webster, MA | 1 |
Brantley, JT; Wise, TN | 1 |
2 review(s) available for medroxyprogesterone acetate and Depression
Article | Year |
---|---|
The relationship between progestin hormonal contraception and depression: a systematic review.
Topics: Contraception; Depression; Drug Implants; Female; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Progestins | 2018 |
Depo-Provera: an ideal contraceptive for adolescents?
Topics: Adolescent; Adolescent Behavior; Contraceptive Agents, Female; Depression; Fatigue; Female; Health Knowledge, Attitudes, Practice; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Patient Selection; Psychology, Adolescent; Weight Gain | 1999 |
13 trial(s) available for medroxyprogesterone acetate and Depression
Article | Year |
---|---|
Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial.
Topics: Adult; Contraception; Contraceptive Agents, Female; Depression; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; South Africa; Young Adult | 2021 |
Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial.
Topics: Adolescent; Adult; Depression; Dysmenorrhea; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; London; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Research Design; Sexual Dysfunction, Physiological; South Africa; Young Adult | 2017 |
Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy.
Topics: Administration, Oral; Adult; Depression; Female; Health Status; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Perimenopause; Postmenopause; Retrospective Studies; Surveys and Questionnaires | 2012 |
An investigational ovarian stimulation protocol increased significantly the psychological burden in women with premature ovarian failure.
Topics: Adolescent; Adult; Anxiety; Buserelin; Chorionic Gonadotropin; Depression; Estrogens; Estrogens, Conjugated (USP); Female; Glucocorticoids; Humans; Infertility, Female; Insemination, Artificial; Longitudinal Studies; Medroxyprogesterone Acetate; Menotropins; Ovary; Ovulation Induction; Prednisone; Primary Ovarian Insufficiency; Prospective Studies; Psychiatric Status Rating Scales; Reproductive Control Agents; Ultrasonography; Young Adult | 2012 |
Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
Topics: Adult; Affect; Cross-Over Studies; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Irritable Mood; Medroxyprogesterone Acetate; Middle Aged | 2003 |
Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens.
Topics: Breast; Contraceptive Agents, Female; Depression; Double-Blind Method; Edema; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Irritable Mood; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Pain; Postmenopause; Predictive Value of Tests; Prospective Studies; Quality of Life; Sleep Initiation and Maintenance Disorders; Sweating | 2004 |
A comparison of the central effects of different progestins used in hormone replacement therapy.
Topics: Administration, Cutaneous; Anxiety; Body Temperature; Depression; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Placebos; Postmenopause; Progestins; Time Factors | 2004 |
Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
Topics: Affect; Aged; Cognition; Depression; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Memory; Middle Aged; Neuropsychological Tests; Progesterone Congeners | 2006 |
A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion.
Topics: Adnexal Diseases; Anxiety; Chronic Disease; Depression; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Pelvic Pain; Pelvis; Phlebography; Prospective Studies; Sexual Dysfunction, Physiological | 2001 |
Changes in quality of life after hormonal treatment of endometriosis.
Topics: Adolescent; Adult; Anxiety; Depression; Double-Blind Method; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nafarelin; Patient Dropouts; Pelvic Pain; Progesterone Congeners; Prospective Studies; Quality of Life; Sleep Wake Disorders; Statistics, Nonparametric; Surveys and Questionnaires | 2001 |
Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.
Topics: Aged; Coronary Artery Disease; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fatigue; Female; Hot Flashes; Humans; Linear Models; Medroxyprogesterone Acetate; Mental Health; Multivariate Analysis; Physical Exertion; Postmenopause; Progesterone Congeners; Quality-Adjusted Life Years | 2002 |
Hormonal treatment and psychological function during the menopausal transition: an evaluation of the effects of conjugated estrogens/cyclic medroxyprogesterone acetate.
Topics: Adult; Anxiety; Depression; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Dropouts; Placebos; Surveys and Questionnaires | 1998 |
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
Topics: Adult; Affect; Breast; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Female; Headache; Humans; Libido; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nausea; Pain; Vaginal Diseases; Vasomotor System | 1998 |
9 other study(ies) available for medroxyprogesterone acetate and Depression
Article | Year |
---|---|
The Association between Immediate Postpartum Depot Medroxyprogesterone Acetate Use and Postpartum Depressive Symptoms.
Topics: Contraceptive Agents, Female; Depression; Depression, Postpartum; Female; Humans; Infant, Newborn; Medroxyprogesterone Acetate; Postpartum Period; Pregnancy; Retrospective Studies | 2023 |
An exploratory analysis of contraceptive method choice and symptoms of depression in adolescent females initiating prescription contraception.
Topics: Adolescent; Choice Behavior; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Depression; Female; Humans; Intrauterine Devices; Logistic Models; Medroxyprogesterone Acetate; Multivariate Analysis; Odds Ratio; Transdermal Patch; Young Adult | 2015 |
The case for hormone replacement: new studies that should inform the debate.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Disease; Depression; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Assessment; Risk Factors | 2002 |
Depression in users of depo-medroxyprogesterone acetate.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Depression; Female; Humans; Medroxyprogesterone Acetate; New York; Poverty Areas; Prevalence; Psychiatric Status Rating Scales; Self Disclosure; Urban Population | 1995 |
Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation.
Topics: Adult; Blood Pressure; Contraceptive Agents, Female; Depression; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Middle Aged; New Zealand; Patient Dropouts; Social Class; Surveys and Questionnaires; Weight Gain | 1997 |
Depressive symptoms and Depo-Provera.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Depression; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Mood Disorders; Prospective Studies; Surveys and Questionnaires | 1998 |
Depressive symptoms in users and non-users of depot medroxyprogesterone acetate.
Topics: Adolescent; Adult; Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Depression; Female; Humans; Injections; Medroxyprogesterone Acetate; Odds Ratio; Pregnancy; Prospective Studies; Time Factors | 2000 |
Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study.
Topics: Adolescent; Adolescent Health Services; Adult; Boston; Contraception; Contraceptive Agents, Female; Depression; Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Surveys and Questionnaires | 2001 |
Antiandrogenic treatment of a gender-dysphoric transvestite.
Topics: Aged; Depression; Diethylstilbestrol; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Transvestism | 1985 |